黄金城集团

资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

The Type II Anti-CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model

Arthritis & rheumatology (Hoboken, N.J.). 2021-05; 
Marinov AD,Wang H,Bastacky SI,van Puijenbroek E,Schindler T,Speziale D,Perro M,Klein C,Nickerson KM,Shlomchik MJ
Products/Services Used Details Operation
Recombinant Proteins (A01967 GenScript).. Get A Quote

摘要

关键词